These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13130168)

  • 61. Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases.
    Verma AK; Manohar M; Upparahalli Venkateshaiah S; Mishra A
    Cytokine Growth Factor Rev; 2017 Dec; 38():37-48. PubMed ID: 28964637
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Significance of changes of gastrointestinal peptides in blood and ileum of experimental spleen deficiency rats.
    Li LS; Qu RY; Wang W; Guo H
    World J Gastroenterol; 2003 Mar; 9(3):553-6. PubMed ID: 12632517
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Intestinal permeability disorders in children].
    Dupont C; Barau E; Molkhou P
    Allerg Immunol (Paris); 1991 Mar; 23(3):95-103. PubMed ID: 2069683
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The relation of vasoactive intestinal peptide and acute hypoxia].
    Li X; Lu WC; Zhu YJ
    Zhonghua Nei Ke Za Zhi; 1990 Jan; 29(1):8-10, 59. PubMed ID: 2401169
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Skin levels of vasoactive intestinal polypeptide in atopic dermatitis.
    Pincelli C; Fantini F; Romualdi P; Lesa G; Giannetti A
    Arch Dermatol Res; 1991; 283(4):230-2. PubMed ID: 1929540
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mechanism of interaction between ocular and nasal neurogenic inflammation in allergic rhinoconjunctivitis.
    Gao XW; Zhang XM; Liu HY; Wang SS; Dong HJ
    Int Ophthalmol; 2019 Oct; 39(10):2283-2294. PubMed ID: 30607863
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vasoactive intestinal polypeptide inhibits the established allergic contact dermatitis in humans.
    Bondesson L; Nordlind K; Mutt V; Lidén S
    Ann N Y Acad Sci; 1996 Dec; 805():702-7. PubMed ID: 8993464
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Neuropeptides in atopic dermatitis in children].
    Vinogradov AI
    Pediatriia; 1991; (5):53-7. PubMed ID: 1866240
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical values of serum neuropeptide changes in patients with chronic urticaria complicated with allergic rhinitis.
    Wang Y; Zhao G
    Ir J Med Sci; 2024 Jun; 193(3):1137-1142. PubMed ID: 37874502
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis.
    Toyoda M; Nakamura M; Makino T; Hino T; Kagoura M; Morohashi M
    Br J Dermatol; 2002 Jul; 147(1):71-9. PubMed ID: 12100187
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Substance P and vasoactive intestinal peptide in patients with progressive scleroderma. Determination of plasma level before and after autogenic training].
    Haustein UF; Weber B; Seikowski K
    Hautarzt; 1995 Feb; 46(2):102-6. PubMed ID: 7535759
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fundamental and clinical evaluation of vasoactive intestinal peptide (VIP) in pancreatitis by radioimmunoassay kit.
    Uehara S; Nakamura T; Ihara K; Isogawa S; Hirayama A
    Radioisotopes; 1987 Jul; 36(7):355-8. PubMed ID: 3317528
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modulating effect of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of peripheral blood T lymphocytes of nickel-allergic patients to nickel sulfate.
    Nordlind K; Mutt V
    Int Arch Allergy Appl Immunol; 1986; 81(4):368-70. PubMed ID: 2430896
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship between vasoactive intestinal peptide and intrapulmonary vascular dilatation in children with various liver diseases.
    Chongsrisawat V; Ampai S; Chotivitayatarakorn P; Sirisopikul T; Poovorawan Y
    Acta Paediatr; 2003 Dec; 92(12):1411-4. PubMed ID: 14971791
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of terfenadine on the plasma concentrations of substance P and vasoactive intestinal polypeptide in volunteers.
    Mori K; Asakura S; Morikawa N; Takeyama M
    J Pharm Pharmacol; 1992 Oct; 44(10):856-8. PubMed ID: 1280680
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils.
    Aliakbari J; Sreedharan SP; Turck CW; Goetzl EJ
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1440-5. PubMed ID: 2446611
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of acupuncture on vasoactive intestinal peptide in ischemic cerebrovascular diseases.
    Zhang X; Yuan Y; Kuang P; Wu W; Zhang F; Liu J
    J Tradit Chin Med; 1997 Dec; 17(4):289-93. PubMed ID: 10437215
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum nitrates and vasoactive intestinal peptide in patients with gastroesophageal reflux disease.
    Kassim SK; El Touny M; El Guinaidy M; El Moghni MA; El Mohsen AA
    Clin Biochem; 2002 Nov; 35(8):641-6. PubMed ID: 12498999
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vasoactive intestinal peptide fluctuates in human blood with a circadian rhythm.
    Cugini P; Lucia P; Di Palma L; Re M; Leone G; Battisti P; Canova R; Gasbarrone L; Cianetti A
    Regul Pept; 1991 Jul; 34(3):141-8. PubMed ID: 1924885
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vasoactive intestinal peptide alleviates food allergy via restoring regulatory B cell functions.
    Zeng HT; Zhao M; Yang SB; Huang H; Geng XR; Liu JQ; Yang G; Li DC; Yang LT; Zheng PY; Yang PC
    Immunobiology; 2019 Nov; 224(6):804-810. PubMed ID: 31471097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.